NCI Director To Keynote Cancer Survivorship Event March 27
"Transforming Cancer Survivorship Through Research and Best Practice, provided by the University of Cincinnati Cancer Institute Survivorship Program, is scheduled for 8 a.m. to 4 p.m. Friday, March 27, at the Kingsgate Marriott Conference Center. Continuing Medical Education credit will be available.
The keynote speaker will be Julia Rowland, PhD, director, National Cancer Institute Office of Cancer Survivorship. In addition, the following will be featured speakers:
Patricia Ganz, MD, UCLA
Timothy Ahles, PhD, Memorial Sloan Kettering Cancer Center
Michael Stubblefield, MD, Memorial Sloan Kettering
Kathryn Schmitz, PhD, University of Pennsylvania
Wendy Demark-Wahnefried, PhD, RD, University of Alabama.
The event is planned to meet the needs of the following practicing health care professionals: physicians, nurses, psychologists, residents, medical students, social workers, counselors and other oncology health professionals.
For a full agenda and registration link, visit uchealth.com/events/transformingsurvivorship/. Early bird registration is available until Feb. 28. With questions, contact Pat Woellert at 513-558-9911 or
Tags
Related Stories
UC expert weighs in on current MASH treatment approaches
June 5, 2026
As MedCentral recently reported, pending broader pharmacologic approvals for metabolic dysfunction-associated steatohepatitis (MASH), lifestyle modifications remain the go-to intervention.
At least two weather patterns increase headaches, UC study suggests
June 4, 2026
University of Cincinnati physicians and collaborators identified two specific weather patterns that increase headache and migraine risk and found the preventive medication fremanezumab (Ajovy) can reduce weather‑associated headaches. The findings will be presented at the American Headache Society Annual Scientific Meeting in Orlando.
UC researcher secures $3.3M grant to study microplastics’ impact on heart
June 2, 2026
The National Institute of Environmental Health Sciences awarded a $3.3M grant to University of Cincinnati researcher Hong‑Sheng Wang, PhD, to study how microplastics and nanoplastics affect cardiovascular health.